Publications by authors named "Annette Koerner"

Claim this Profile
H
Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemia.
Ali T Taher, Vip Viprakasit, Maria Domenica Cappellini, Dominik Kraus, Patrick Cech, Annette Koerner

Br J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia.
Alessandro Matte, Enrica Federti, Michael Winter, Annette Koerner, Anja Harmeier

JCI Insight· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient.
Emmanuel Pinard, Edilio Borroni, Annette Koerner, Daniel Umbricht, Daniela Alberati

Chimia (Aarau)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety assessments in the cynomolgus monkey: Unmasking potential background arrhythmias in general toxicity studies.
Andrea Greiter-Wilke, Ted Baird, Kyle O'Donohue, Annette Koerner

J Pharmacol Toxicol Methods· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) Inhibitor.
Paul Barrow, Neil Parrott, Daniela Alberati, Axel Paehler, Annette Koerner

Birth Defects Res B Dev Reprod Toxicol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
Stephen Toovey, Eric P Prinssen, Craig R Rayner, Bharat T Thakrar, Regina Dutkowski, Annette Koerner

Adv Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a physiologically based model for oseltamivir and simulation of pharmacokinetics in neonates and infants.
Neil Parrott, Brian Davies, Gerhard Hoffmann, Annette Koerner, Thierry Lave

Clin Pharmacokinet· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis